SCHEMBL5147336

SCHEMBL5147336

C=Cc1cc(-c2nc(NCCN3C(=O)NC(C)(C)C3=O)ncc2Cl)sc1Cc1ccc(F)cc1

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 1/20 0.35
MAPK1 P28482 1/20 0.34
ALDH1A1 P00352 5/20 0.33
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
GRM2 Q14416 1/20 0.33
HTT P42858 1/20 0.32
AXL P30530 2/20 0.32
GAA P10253 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
RAB9A P51151 2/20 0.31
NPC1 O15118 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
JAK3 P52333 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2981950 0.87 MAPK1 (0.33) MAPK1ALDH1A1AXLMEN1KMT2A
SCHEMBL5147508 0.76 PLA2G7 (0.34) PLA2G7ALDH1A1GRM2HTTSMN1; SMN2
SCHEMBL5149162 0.76 PLA2G7 (0.40) PLA2G7MAPK1ALDH1A1KDM4EGRM2
SCHEMBL5145980 0.75 MAPK8 (0.34) PLA2G7ALDH1A1GRM2AXL
SCHEMBL5148389 0.75 CA1 (0.35) PLA2G7ALDH1A1GRM2
SCHEMBL5147316 0.74 PLA2G7 (0.39) PLA2G7MAPK1ALDH1A1KDM4EGRM2
SCHEMBL5147520 0.74 PLA2G7 (0.35) PLA2G7ALDH1A1GRM2
SCHEMBL5147391 0.73 PLA2G7 (0.38) PLA2G7MAPK1ALDH1A1KDM4EHTT
SCHEMBL5148399 0.71 PLA2G7 (0.39) PLA2G7MAPK1ALDH1A1GRM2HTT
SCHEMBL2973156 0.70 CDK1 (0.40) MAPK1AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed